BR112014013639A8 - carbonato de sódio anidroso tendo um teor de poro baixo - Google Patents

carbonato de sódio anidroso tendo um teor de poro baixo

Info

Publication number
BR112014013639A8
BR112014013639A8 BR112014013639A BR112014013639A BR112014013639A8 BR 112014013639 A8 BR112014013639 A8 BR 112014013639A8 BR 112014013639 A BR112014013639 A BR 112014013639A BR 112014013639 A BR112014013639 A BR 112014013639A BR 112014013639 A8 BR112014013639 A8 BR 112014013639A8
Authority
BR
Brazil
Prior art keywords
sodium carbonate
anhydrous sodium
low pore
pore content
content
Prior art date
Application number
BR112014013639A
Other languages
English (en)
Other versions
BR112014013639A2 (pt
BR112014013639B1 (pt
Inventor
Moddelmog Guenter
Peth Hans-Kurt
Klatyk Jens
Wedel Thorsten
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR112014013639A2 publication Critical patent/BR112014013639A2/pt
Publication of BR112014013639A8 publication Critical patent/BR112014013639A8/pt
Publication of BR112014013639B1 publication Critical patent/BR112014013639B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C01D7/07—Preparation from the hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C01D7/12—Preparation of carbonates from bicarbonates or bicarbonate-containing product
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C01D7/22—Purification
    • C01D7/26—Purification by precipitation or adsorption
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D7/00—Carbonates of sodium, potassium or alkali metals in general
    • C01D7/35—Varying the content of water of crystallisation or the specific gravity
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/01—Particle morphology depicted by an image
    • C01P2004/03—Particle morphology depicted by an image obtained by SEM
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/10—Solid density
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/11—Powder tap density
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity
    • C01P2006/82—Compositional purity water content

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

resumo patente de invenção: "carbonato de sódio anidroso tendo um teor de poro baixo". a presente invenção refere-se a carbonato de sódio altamente puro, anidroso tendo um teor de poro baixo para uso em formulações farmacêuticas e na indústria de alimentos. além disso, um novo processo para a preparação deste carbonato de sódio é fornecido. 21361567v1 1/1 21361567v1
BR112014013639-4A 2011-12-09 2012-11-10 Carbonato de sódio cristalino, seus usos e seu processo de preparação BR112014013639B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11009721 2011-12-09
EP11009721.9 2011-12-09
PCT/EP2012/004679 WO2013083226A1 (de) 2011-12-09 2012-11-10 Porenarmes, wasserfreies natriumcarbonat

Publications (3)

Publication Number Publication Date
BR112014013639A2 BR112014013639A2 (pt) 2017-06-13
BR112014013639A8 true BR112014013639A8 (pt) 2017-06-13
BR112014013639B1 BR112014013639B1 (pt) 2022-05-10

Family

ID=47172587

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014013639-4A BR112014013639B1 (pt) 2011-12-09 2012-11-10 Carbonato de sódio cristalino, seus usos e seu processo de preparação

Country Status (11)

Country Link
US (1) US9388053B2 (pt)
EP (1) EP2788289B1 (pt)
JP (1) JP6279481B2 (pt)
KR (1) KR102049213B1 (pt)
CN (1) CN103998378B (pt)
BR (1) BR112014013639B1 (pt)
CA (1) CA2858422C (pt)
ES (1) ES2753129T3 (pt)
MX (1) MX2014006720A (pt)
PT (1) PT2788289T (pt)
WO (1) WO2013083226A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104591227B (zh) * 2015-01-31 2017-02-22 湖南尔康制药股份有限公司 一种无水碳酸钠纳米颗粒的制备方法
EP3239109A1 (en) * 2016-04-28 2017-11-01 Omya International AG Surface-treated mineral material and its use in water purification

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321268A (en) * 1963-09-25 1967-05-23 Allied Chem Conversion of caustic soda to soda ash
JPS4626101Y1 (pt) 1967-12-27 1971-09-08
JPS557530A (en) * 1978-06-30 1980-01-19 Toyo Soda Mfg Co Ltd Manufacture of anhydrous sodium carbonate
JPS56109818A (en) * 1980-02-01 1981-08-31 Asahi Glass Co Ltd Manufacture of anhydrous sodium carbonate crystal
JPH0626101B2 (ja) 1984-01-06 1994-04-06 株式会社日立製作所 マグネトロン
RO104033B1 (en) * 1989-11-30 1992-03-02 Combinatul Chimic Rimnicu Vilc Preparation method of pure sodium carbonate
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
DE670160T1 (de) 1994-03-01 1996-03-14 Gerhard Gergely Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung.
ES2136157T3 (es) * 1994-03-01 1999-11-16 Gerhard Gergely Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
FR2722772B1 (fr) * 1994-07-19 1996-09-27 Solvay Procede de fabrication de carbonate de sodium anhydre
US5788947A (en) * 1994-08-09 1998-08-04 Ruiz-Luna; Raymundo Method for the production of anhydrous alkali metal carbonates
JP2004506609A (ja) 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
WO2007144418A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Oral pharmaceutical composition of a poorly water-soluble active substance
CN101712480A (zh) * 2008-10-06 2010-05-26 天津市化学试剂研究所 无水碳酸钠的制备方法

Also Published As

Publication number Publication date
KR20140110921A (ko) 2014-09-17
EP2788289A1 (de) 2014-10-15
US20140336273A1 (en) 2014-11-13
WO2013083226A8 (de) 2013-08-01
CN103998378B (zh) 2016-12-14
PT2788289T (pt) 2019-10-25
MX2014006720A (es) 2014-07-09
BR112014013639A2 (pt) 2017-06-13
ES2753129T3 (es) 2020-04-07
JP6279481B2 (ja) 2018-02-14
KR102049213B1 (ko) 2019-11-28
EP2788289B1 (de) 2019-07-31
WO2013083226A1 (de) 2013-06-13
US9388053B2 (en) 2016-07-12
JP2015500195A (ja) 2015-01-05
CA2858422A1 (en) 2013-06-13
BR112014013639B1 (pt) 2022-05-10
CA2858422C (en) 2020-01-07
CN103998378A (zh) 2014-08-20

Similar Documents

Publication Publication Date Title
BR112013023829A2 (pt) âncora de sutura plana
BR112015002372A2 (pt) composições e métodos para a redução do teor de álcool no sangue
BR112014029754B1 (pt) soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição
PE20150964A1 (es) Formulaciones acuosas estables de adalimumab
PH12016500105A1 (en) Sulfonamides as modulators of sodium channels
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
BR112015023827A2 (pt) composições de limpeza contendo uma poliéter amina
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
MX356951B (es) Estabilizacion de fsh.
BR112014029185A2 (pt) nucleosídeos de spirooxetano uracila
BR112015011244A8 (pt) análogos de compstatina de reação celular, ação longa ou direcionados e composições e métodos relacionados
BR112013020620A2 (pt) análogos de ácido 4-hidroxibutírico
BR112015029088A2 (pt) sistema de múltiplas bateladas para preparar uma solução de hidrogeno carbonato de cálcio, e, uso de uma solução de hidrogeno carbonato de cálcio
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
BR112015008954A2 (pt) composições de ciclodextrina alquilatada e processos para preparação e uso das mesmas
BR112013022213A2 (pt) administração parenteral de tapentadol
BR112013019218A2 (pt) material particulado
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
BR112014001299A2 (pt) forma cristalina do sal de sódio de 4-terc-butil-n-[4-cloro-2-(1-óxi-piridina-4-carbonil)-fenil]-benzenossulfonamida
BR112015028824A2 (pt) composição de tensoativo concentrada
BR112014013639A8 (pt) carbonato de sódio anidroso tendo um teor de poro baixo
CL2011002278A1 (es) Proceso para la preparacion de (e)-n-(4-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxiestiril)fenil)metansulfonamida o su sal por reduccion del correspondiente etinilo; y los compuestos intermediarios considerados.
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
BR112014015357A2 (pt) método para a preparação de partículas de proteína precipitada amorfa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/11/2012, OBSERVADAS AS CONDICOES LEGAIS